Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

NCT00519805 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Lung Cancer
Thromboembolism

Interventions

DRUG: dalteparin
PROCEDURE: quality-of-life assessment

Sponsor

Velindre NHS Trust